EyeGene Market Cap

EyeGene has a market cap or net worth of 74.06 billion as of April 1, 2025. Its market cap has decreased by -9.27% in one year.

Market Cap

74.06B

Enterprise Value

46.05B

Revenue

3.36B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,720.00

Market Cap Chart

Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 74.06B, a decrease of -43.46%. That is a compound annual growth rate of -5.90%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	72.30B	4.49%
Dec 30, 2024	69.20B	-24.46%
Dec 28, 2023	91.61B	-15.21%
Dec 29, 2022	108.04B	-73.58%
Dec 30, 2021	408.92B	175.32%
Dec 30, 2020	148.53B	11.93%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	396.83T
SK hynix	137.33T
LG Energy Solution	83.30T
Samsung Biologics	74.66T
Hyundai Motor Company	44.69T
Celltrion	38.03T
Kia Corporation	37.52T
KB Financial Group	29.19T

Market Cap Rankings